FIN-CERAMICA FAENZA SPA

Their core work

FIN-CERAMICA FAENZA is an Italian industrial ceramics company based in Faenza — a city historically renowned for ceramic production. Within H2020, they contribute advanced ceramic and biomaterial manufacturing expertise to health-oriented research, particularly in nano-biomaterials for drug delivery and biomedical implants. Their work spans from producing bioinspired nanoparticles for cardiovascular therapies to supporting the development of safety and risk management frameworks for nano-biomaterials. They serve as a materials supplier and manufacturing partner, bridging the gap between laboratory-scale biomaterial research and industrial-grade production.

What they specialise in

How they've shifted over time

FIN-CERAMICA's early H2020 involvement (2017) centered on therapeutic applications — developing bioinspired nanoparticles for cardiovascular drug delivery through the CUPIDO project. By 2017-2018, their focus broadened to include the safety and regulatory dimension of nano-biomaterials via BIORIMA, with keywords shifting toward risk management frameworks, safer-by-design approaches, and validated testing methods. This suggests a maturation from pure materials development toward responsible innovation, addressing the full lifecycle from fabrication through safety validation.

Moving from pure biomaterial production toward safety-conscious, regulation-ready nano-biomaterials — a valuable position as EU regulatory requirements for medical nanomaterials tighten.

How they like to work

FIN-CERAMICA operates exclusively as a consortium participant, never leading projects, which is consistent with their role as a specialized industrial materials partner contributing manufacturing capability to research-led consortia. Despite only three projects, they have worked with 56 unique partners across 20 countries, indicating they join large, diverse consortia rather than small focused teams. This broad network suggests they are a trusted industrial partner that research groups recruit when they need real-world ceramics and biomaterials production expertise.

With 56 unique consortium partners spanning 20 countries from just 3 projects, FIN-CERAMICA has an unusually wide European network for its project count, reflecting participation in large multi-national research consortia. Their connections are pan-European with no obvious geographic concentration beyond Italy.

What sets them apart

FIN-CERAMICA occupies a specific niche as an industrial ceramics manufacturer that operates at the intersection of materials science and biomedical applications. Unlike university labs that develop biomaterials at bench scale, they bring industrial production capability — making them the partner you need when a project requires real manufactured ceramic or nano-biomaterial samples rather than laboratory prototypes. Their combined experience in both therapeutic biomaterials (CUPIDO) and safety assessment (BIORIMA) means they understand the full path from material fabrication to regulatory readiness.

Highlights from their portfolio

• CUPIDO
  Largest funding (EUR 490,000) and an ambitious concept — inhalable bioinspired nanoparticles for needle-free cardiovascular drug delivery, combining ceramics with targeted therapy.
• BIORIMA
  Addressed a critical gap in nano-biomaterial commercialization by building risk management and safer-by-design frameworks, directly relevant to regulatory approval pathways.